To our knowledge, a specific relationship between CRP and monoaminergic antidepressant drug treatment resistance has not been demonstrated previously, although there is evidence both for increased proinflammatory cytokine concentrations3,14,49 and for increased peripheral expression of cytokine related genes12 in treatment-resistant depression. This evidence concerns the gene CRP and depressive symptom measurement.